Compounds and methods are provided for the alleviation or treatment of diseases or conditions in which modification of muscarinic m1 receptor activity has a beneficial effect. In the method, a therapeutically effective amount of a selective muscarinic m1 agonist compound is administered to a patient in need of such treatment.


< Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication

> Aminopterin Dosage Forms and Methods for Inflammatory Disorders

~ 00429